• Je něco špatně v tomto záznamu ?

A tüdőrák molekuláris diagnosztikája [Molecular diagnostics of lung cancer]

A. Ryska, R. Dziadziuszko, W. Olszewski, P. Berzinec, B. Öz, M. Gottfried, T. Cufer, M. Samarzija, L. Plank, G. Ostoros, J. Tímár,

. 2015 ; 59 (3) : 259-66. [pub] 20150818

Jazyk maďarština Země Maďarsko

Typ dokumentu anglický abstrakt, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000033

Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.

Molecular diagnostics of lung cancer

000      
00000naa a2200000 a 4500
001      
bmc16000033
003      
CZ-PrNML
005      
20160209100428.0
007      
ta
008      
160108s2015 hu f 000 0|hun||
009      
AR
035    __
$a (PubMed)26339915
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a hun
044    __
$a hu
100    1_
$a Ryska, A $u The Fingerland Department of Pathology, Charles University, Hradec Kralove, Czech Republic.
245    12
$a A tüdőrák molekuláris diagnosztikája / $c A. Ryska, R. Dziadziuszko, W. Olszewski, P. Berzinec, B. Öz, M. Gottfried, T. Cufer, M. Samarzija, L. Plank, G. Ostoros, J. Tímár,
246    31
$a [Molecular diagnostics of lung cancer]
520    9_
$a Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.
650    _2
$a nemalobuněčný karcinom plic $x diagnóza $x farmakoterapie $x genetika $7 D002289
650    _2
$a konsensus $7 D032921
650    _2
$a genová přestavba $7 D015321
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x diagnóza $x farmakoterapie $x genetika $7 D008175
650    _2
$a cílená molekulární terapie $x metody $7 D058990
650    _2
$a mutace $7 D009154
650    _2
$a molekulární patologie $x metody $7 D057089
650    _2
$a týmová péče o pacienty $7 D010348
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a protoonkogenní proteiny $x genetika $7 D011518
650    _2
$a tyrosinkinasové receptory $x genetika $7 D020794
650    _2
$a erbB receptory $x genetika $7 D066246
650    _2
$a ras proteiny $x genetika $7 D018631
651    _2
$a Evropa $7 D005060
655    _2
$a anglický abstrakt $7 D004740
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Dziadziuszko, R $u Department of Radiation Therapy and Oncology, Gdansk Medical University, Gdansk, Poland.
700    1_
$a Olszewski, W $u Maria Sklodovska-Curie Institute, Oncology Center, Warshaw, Poland.
700    1_
$a Berzinec, P $u Spec. Hospital St Zoerardus Zobor, Nitra, Slovakia.
700    1_
$a Öz, B $u Istambul University, Istambul, Turkey.
700    1_
$a Gottfried, M $u Department of Lung Cancer, Meir Hospital, Tel Aviv, Israel.
700    1_
$a Cufer, T $u University Clinic Golnic, University of Ljubjana, Ljubjana, Slovenia.
700    1_
$a Samarzija, M $u Poliklinika Apnea, Zagreb, Croatia.
700    1_
$a Plank, L $u Department of Pathology, Comenius University, Martin, Slovakia.
700    1_
$a Ostoros, Gy $u National Korányi Lung Institute, Budapest, Hungary.
700    1_
$a Tímár, J $u 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
773    0_
$w MED00011630 $t Magyar onkologia $x 0025-0244 $g Roč. 59, č. 3 (2015), s. 259-66
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26339915 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20160209100607 $b ABA008
999    __
$a ok $b bmc $g 1102314 $s 924239
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 59 $c 3 $d 259-66 $e 20150818 $i 0025-0244 $m Magyar onkologia $n Magy Onkol $x MED00011630
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Možnosti archivace